Please upgrade your browser.
People are living longer with kidney cancer than ever before.
Around 45,000 people will benefit from new, cheaper medicines following the Governmentâs approval of eleven new medicines on the Pharmaceutical Benefits Scheme.
What scientists have characterized as the deluge of information that has emerged from genome-scale studies has forced parallel development of new analytical frameworks and tools.
The following manuscript will endeavor to provide an overview of this uncommon entity including pathology, epidemiology, genetics, clinical aspects, and current and future treatment options.
It wasnât the greatest weekend to bike more than 200 kilometers, but it was nowhere near the worst thing theyâve been through.
âItâs been very rewarding,â said Dr. Bin Tean Teh, the lead researcher in the study. âWhen somebody close to you has (the cancer), obviously the impact is greater. It makes it more personal, more passionate.â
Governor Patrick Quinn of Illinois visited the BIO International Convention to talk about the biotech sector in his state, built on a solid foundation of commercial, R&D and academic communities.
Interview: Jeremy Abbate, Director, Global Media Solutions with Scientific American
News and views from the Kidney Cancer Association. The June-July, 2012, edition of our newsletter features information about a new book written by a kidney cancer survivor for patients newly diagnosed with the disease, along with news about how you can help Team KCA in the Chicago Women's Half Marathon this weekend.
Review: Cancer Clinical Trials: A Commonsense Guide to Experimental Cancer Therapies and Clinical Trials
|Powered by NeonCRM|